The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 73

More JCP Articles

JCP
Educational Activity

March 17, 2020

When you are treating a patient for depression, do you regularly assess symptoms, adherence, and side effects using tools and then use that information to guide treatment decisions? Learn…
JCP
Educational Activity

March 17, 2020

Identification of depression is crucial, as untreated depression is linked to functional impairment and suicide. Learn from an expert about how measurement-based care provides a way to improve the…
JCP
Meta-Analysis

March 10, 2020

Some women experience severe affective episodes outside the postpartum period after an initial episode of postpartum psychosis, though others do not. This meta-analysis estimates the risk of recurrence after…
, , , et al
JCP
Original Research

March 10, 2020

Alcohol use disorder is comorbid in 33% of US patients with schizophrenia. Testing the tolerability of olanzapine and samidorphan until the first event of exacerbation of disease symptoms is…
, , , et al
JCP
Commentary

March 3, 2020

Read commentary on the possible reasons why placebo response rates in clinical trials for schizophrenia are increasing.
JCP
Original Research

March 3, 2020

Read a study evaluating the antipsychotic efficacy and safety of OLZ/SAM compared with placebo in patients with an acute exacerbation of schizophrenia.
, , , et al
JCP
Original Research

March 3, 2020

Experiencing a first episode of schizophrenia during adolescence may influence response to cognitive training. This study compared response to cognitive training in patients with early-onset schizophrenia versus those with…
, , , et al
JCP
Review Article

March 3, 2020

Efficacy trials in schizophrenia patients conducted from 1991 to 2009 showed an increasing rate of placebo response and a decline in treatment effect over time. This study explores these…
, , , et al
JCP
Original Research

February 25, 2020

Insomnia is a risk factor for suicide, and suicide risk is highest at night. Read this report to learn if this nocturnal risk is affected by other variables such…
, , , et al
JCP
Meta-Analysis

February 25, 2020

Varenicline reduces smoking. Since alcohol use and tobacco use disorders are often comorbid, does the effectiveness of varenicline in reducing tobacco use translate to a similar effectiveness for alcohol-related…
, , , et al
JCP
Original Research

February 18, 2020

This study sought to clarify how reward deficits and striatal circuitry are involved in acute episodes as well as remission of major depressive disorder—and how the findings may help…
, , , et al
JCP
Academic Highlights

February 18, 2020

What should you rule out to diagnose tardive dyskinesia (TD)? How do treatment options differ? In this journal CME activity, Drs Citrome and Saklad team up to review the…
,

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe